Leveraging and Protecting Cannabis Brands Following CSA Rescheduling

3 months ago

September 9, 2024 Authors Adam J. Fromm , Clifford Cooper II This is an exciting time for cannabis entrepreneurs as the US government is poised to reclassify cannabis as a Schedule III drug in a move that recognizes cannabis’ medical and therapeutic uses and may open the door for new cannabis trademark registrations. Capitalizing on these changes […]